Palisade Bio (PALI) Other Operating Expenses (2010 - 2026)
Palisade Bio (PALI) reported Other Operating Expenses of -$3.8 million for Q1 2026, down 183.67% year-over-year from $4.6 million in Q1 2025, and down 7.03% quarter-over-quarter from -$3.6 million in Q4 2025.
Palisade Bio (PALI) Other Operating Expenses (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 10 years of Other Operating Expenses data on file, last reported at -$3.8 million in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at -$3.8 million, down 183.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.1 million (up 47.94% YoY), and the FY2025 annual result was -$7.6 million, down 38.37% from the prior year.
- Other Operating Expenses fell to -$3.8 million in Q1 2026 per PALI's latest filing, from -$3.6 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $1.2 million in Q4 2023 and troughed at -$15.1 million in Q3 2024.
- A 5-year average of -$2.6 million and a median of -$1.4 million in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses sank 212.07% in 2024, then surged 89.94% in 2025.
- A 5-year view of Other Operating Expenses shows it stood at $410000.0 in 2022, then soared by 200.98% to $1.2 million in 2023, then slumped by 212.07% to -$1.4 million in 2024, then sank by 158.13% to -$3.6 million in 2025, then decreased by 7.03% to -$3.8 million in 2026.
- Business Quant data shows PALI's Other Operating Expenses at -$3.8 million in Q1 2026, -$3.6 million in Q4 2025, and -$1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.82 Mn |
| Dec 31, 2025 | -3.57 Mn |
| Sep 30, 2025 | -1.52 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Mar 31, 2025 | -1.35 Mn |
| Dec 31, 2024 | -1.38 Mn |
| Sep 30, 2024 | -15.10 Mn |
| Jun 30, 2024 | -1.48 Mn |
| Mar 31, 2024 | -1.38 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2022 | 410,000.00 |
| Jun 30, 2021 | 30.12 Mn |
| Dec 31, 2013 | 171.00 |
| Sep 30, 2013 | 293.00 |
| Jun 30, 2013 | 50,636.00 |
| Mar 31, 2013 | 50,093.00 |
| Dec 31, 2012 | 219.00 |
| Sep 30, 2012 | 692.00 |
| Mar 31, 2012 | 2,573.00 |
| Mar 31, 2011 | 250,000.00 |